CLINICAL_TRIALS
trial_result
· 2016-01-20
Clinical Trial Update: Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer [Phase 2]
Summary
Phase 2 study of Abraxane (nab-paclitaxel) in metastatic colorectal cancer has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2016-01-20